Review



human thp1  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    InvivoGen human thp1
    (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in <t>THP1-Dual-derived</t> macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.
    Human Thp1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 586 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-Dual+Cells/pmc13367702-167-0-10
    Average 99 stars, based on 586 article reviews
    human thp1 - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production"

    Article Title: Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production

    Journal: PLOS Pathogens

    doi: 10.1371/journal.ppat.1014364

    (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in THP1-Dual-derived macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.
    Figure Legend Snippet: (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in THP1-Dual-derived macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.

    Techniques Used: Gene Expression, Membrane, Infection, Knock-Out, Sequencing, Derivative Assay, Two Tailed Test, Analysis, Expressing, Significance Assay

    (a) Interferon (IFN)-β secretion in J774a.1 macrophages pre-treated with Triton X-100, subjected to freeze–thaw cycles, or sonicated (2 cycles of 25 s each with 5 s pause at 30% power on ice) before being stimulated with Ab908 membrane vesicles (MVs). (b) IFN-β secretion in J774a.1 macrophages pre-treated with DNase I, RNase A, proteinase K, or polymyxin B for 30 min before being stimulated with MVs. (c) IFN-β secretion in THP1-Dual-derived macrophages pre-treated with TAK242 (Toll-like receptor 4 [TLR4] inhibitor) for 1 h and L48H37 (Myeloid differentiation factor-2 [MD-2] inhibitor) for 0.5 h before being stimulated with MVs. (d) IFN-β and (e) TNF-α secretion in THP1-Dual-derived macrophages pre-treated with anti-human CD14 antibody (hCD14) or anti-human IgG (hIgG, control) for 1 h before being stimulated with MVs (multiplicity of infection [MOI] = 500) from different bacterial strains. Cytokines were measured using an enzyme-linked immunosorbent assay 4 h after stimulation. The concentrations used were as follows: Triton X-100 (0.1% vol/vol); DNase I, 1 U/μL; RNase A, 200 μg/mL; proteinase K, 100 μg/mL; polymyxin B, 3 μM; TAK242, 1 μM; L48H37, 10 μM; hIgG, 10 μg/mL; hCD14, 10 μg/mL. Statistical significance was determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01, *** P < 0.001.
    Figure Legend Snippet: (a) Interferon (IFN)-β secretion in J774a.1 macrophages pre-treated with Triton X-100, subjected to freeze–thaw cycles, or sonicated (2 cycles of 25 s each with 5 s pause at 30% power on ice) before being stimulated with Ab908 membrane vesicles (MVs). (b) IFN-β secretion in J774a.1 macrophages pre-treated with DNase I, RNase A, proteinase K, or polymyxin B for 30 min before being stimulated with MVs. (c) IFN-β secretion in THP1-Dual-derived macrophages pre-treated with TAK242 (Toll-like receptor 4 [TLR4] inhibitor) for 1 h and L48H37 (Myeloid differentiation factor-2 [MD-2] inhibitor) for 0.5 h before being stimulated with MVs. (d) IFN-β and (e) TNF-α secretion in THP1-Dual-derived macrophages pre-treated with anti-human CD14 antibody (hCD14) or anti-human IgG (hIgG, control) for 1 h before being stimulated with MVs (multiplicity of infection [MOI] = 500) from different bacterial strains. Cytokines were measured using an enzyme-linked immunosorbent assay 4 h after stimulation. The concentrations used were as follows: Triton X-100 (0.1% vol/vol); DNase I, 1 U/μL; RNase A, 200 μg/mL; proteinase K, 100 μg/mL; polymyxin B, 3 μM; TAK242, 1 μM; L48H37, 10 μM; hIgG, 10 μg/mL; hCD14, 10 μg/mL. Statistical significance was determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01, *** P < 0.001.

    Techniques Used: Sonication, Membrane, Derivative Assay, Control, Infection, Enzyme-linked Immunosorbent Assay, Two Tailed Test

    (a) Tumor necrosis factor (TNF)-α production in THP1-Dual-derived macrophages pre-treated with polymyxin B (3 μM) and subsequently stimulated with membrane vesicles (MVs) from different bacterial strains (multiplicity of infection [MOI] =500). (b) TNF-α levels in THP1-Dual-derived macrophages 6 h after being stimulated with MVs released from the parent strains and their Re-LOS mutants belonging to different sequence types. (c)-(d) Activation of NF-κB and interferon regulator factor (IRF) pathways in THP1-Dual cells based on the activities of secreted embryonic alkaline phosphatase (SEAP) and luciferase, respectively. (e) Expression of interferon regulatory factor 3 (IRF3) and phosphorylated IRF3 (p-IRF3) in J774a.1 cells at 1 h and 6 h post-stimulation with MVs from different strains. (f) IFN-β production at 4 h post-stimulation with MVs (MOI = 500) in the presence or absence of IKKε/TBK1 inhibitor MRT67307 (10 μM, pre-treated for 1 h) . (g) mRNA expression in J774a.1 cell at 2 h post-stimulation with MVs. (h) Expression levels of MyD88-associated genes in cells stimulated with MVs. (i)-(j) TNF-α and IFN-β secretion in macrophages derived from (i) THP1-Dual KO‑TRIF cells and (j ) THP1-Dual KO‑MyD88 cells at 6 h post-stimulation with MVs. Means and standard errors of the means from the three biological replicates are presented, with significance determined using unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. LPS, lipopolysaccharide.
    Figure Legend Snippet: (a) Tumor necrosis factor (TNF)-α production in THP1-Dual-derived macrophages pre-treated with polymyxin B (3 μM) and subsequently stimulated with membrane vesicles (MVs) from different bacterial strains (multiplicity of infection [MOI] =500). (b) TNF-α levels in THP1-Dual-derived macrophages 6 h after being stimulated with MVs released from the parent strains and their Re-LOS mutants belonging to different sequence types. (c)-(d) Activation of NF-κB and interferon regulator factor (IRF) pathways in THP1-Dual cells based on the activities of secreted embryonic alkaline phosphatase (SEAP) and luciferase, respectively. (e) Expression of interferon regulatory factor 3 (IRF3) and phosphorylated IRF3 (p-IRF3) in J774a.1 cells at 1 h and 6 h post-stimulation with MVs from different strains. (f) IFN-β production at 4 h post-stimulation with MVs (MOI = 500) in the presence or absence of IKKε/TBK1 inhibitor MRT67307 (10 μM, pre-treated for 1 h) . (g) mRNA expression in J774a.1 cell at 2 h post-stimulation with MVs. (h) Expression levels of MyD88-associated genes in cells stimulated with MVs. (i)-(j) TNF-α and IFN-β secretion in macrophages derived from (i) THP1-Dual KO‑TRIF cells and (j ) THP1-Dual KO‑MyD88 cells at 6 h post-stimulation with MVs. Means and standard errors of the means from the three biological replicates are presented, with significance determined using unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. LPS, lipopolysaccharide.

    Techniques Used: Derivative Assay, Membrane, Infection, Sequencing, Activation Assay, Luciferase, Expressing, Two Tailed Test, Western Blot

    (a) Interferon (IFN)-β measurement in THP1-Dual-derived macrophages (5 × 10 5 /well) pre-treated with dynasore (endocytosis inhibitor, 80 μM) for 1 h, piceatannol (Syk inhibitor, 75 μM), or U-73122 (PLCγ2 inhibitor, 5 μM) for 0.5 h before being stimulated with membrane vesicles (MVs) from different strains (multiplicity of infection [MOI] = 500, 4 h) . n = 3 biological replicates per group. (b)-(d) Flow cytometry results of endocytosis of (b ) CD14, (c ) Toll-like receptor 4 (TLR4), and (d) TLR4/Myeloid differentiation factor-2 (MD-2) dimerization in J774a.1 cells stimulated with MVs for the indicated times. Error bars represent mean ± standard error of the mean (SEM) from triplicate experiments. MFI, mean fluorescence intensity. The means and standard error of mean from three biological replicates are presented, with significance determined by unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001. LPS, lipopolysaccharide.
    Figure Legend Snippet: (a) Interferon (IFN)-β measurement in THP1-Dual-derived macrophages (5 × 10 5 /well) pre-treated with dynasore (endocytosis inhibitor, 80 μM) for 1 h, piceatannol (Syk inhibitor, 75 μM), or U-73122 (PLCγ2 inhibitor, 5 μM) for 0.5 h before being stimulated with membrane vesicles (MVs) from different strains (multiplicity of infection [MOI] = 500, 4 h) . n = 3 biological replicates per group. (b)-(d) Flow cytometry results of endocytosis of (b ) CD14, (c ) Toll-like receptor 4 (TLR4), and (d) TLR4/Myeloid differentiation factor-2 (MD-2) dimerization in J774a.1 cells stimulated with MVs for the indicated times. Error bars represent mean ± standard error of the mean (SEM) from triplicate experiments. MFI, mean fluorescence intensity. The means and standard error of mean from three biological replicates are presented, with significance determined by unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001. LPS, lipopolysaccharide.

    Techniques Used: Derivative Assay, Membrane, Infection, Flow Cytometry, Fluorescence, Two Tailed Test

    Related Articles

    Cell Culture:

    Article Title: P2Y2 purinergic receptor and DNA sensor cGAS dictate ionizing radiation-mediated proinflammatory macrophage activation
    Article Snippet: .. Human THP1 cells were differentiated into THP1 macrophages with 320 nM of PMA (#tlrl-PMA, Invivogen, USA) during 24 hours and cultured for additional 24 hours before use. ..



    Similar Products

    99
    InvivoGen human thp1
    (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in <t>THP1-Dual-derived</t> macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.
    Human Thp1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-Dual+Cells/pmc13367702-167-0-10
    Average 99 stars, based on 1 article reviews
    human thp1 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen human monocytic inflammasome asc speck reporter cells
    (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in <t>THP1-Dual-derived</t> macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.
    Human Monocytic Inflammasome Asc Speck Reporter Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-ASC-GFP+Cells/10__1038_slash_s44400___026___00122___7-261-0-11
    Average 99 stars, based on 1 article reviews
    human monocytic inflammasome asc speck reporter cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen thp 1 blue nf κβ human monocytes
    (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in <t>THP1-Dual-derived</t> macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.
    Thp 1 Blue Nf κβ Human Monocytes, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-Blue+NF-%CE%BAB+Cells/10__1016_slash_j__bcdf__2026__100543-89-21-26
    Average 99 stars, based on 1 article reviews
    thp 1 blue nf κβ human monocytes - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC human thp1 cells
    ( A ) Schematic workflow of proteomic and transcriptomic analyses across both model <t>THP1</t> monocytes ( left ), and patient derived control and VEXAS monocytes ( right ) to identify disease initiating pathways. ( B ) Loss of cytoplasmic UBA1 function in THP1 model cells leads to ERAD dysregulation, UPR activation, and inflammatory signaling without evidence for cell death. UBA1 WT and UBA1 M41V THP1 cells were treated with dox for 9 d and subjected to immunoblotting using the indicated antibodies. Results are representative of n ≥ 3 biological replicates. ( C ) THP1 VEXAS model cells exhibit type I interferon signatures, confirming the results of the transcriptomic analyses. Parental, UBA1-/-, UBA1 WT and UBA1 M41V/L THP1 monocytes or macrophages (M ϕ) were treated with dox for 9 d and analyzed by qPCR for an Interferon Score by averaging the fold change of 6-hallmark ISGs (IFI44L, IFI27, IFIT1, ISG15, RSAD2, and SIGLEC1). n ≥ 3 biological replicates, error bars = s.e.m., **** = p < 0.0001, student’s t-test. ( D ) Loss of cytoplasmic UBA1 function in THP1 model cells leads to multi-cytokine inflammation. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were treated with dox for 9 d and ELISA for IL-6, TNFα, IL-1b, and CXCL-10. n = 3 biological replicates, ** = p < 0.01, error bar = s.e.m, student’s t-test. ( E ) Proteomic and transcriptomic analyses reveal overlapping and unique altered pathways in VEXAS and nominate ERAD and Golgi transport dysregulation as initial signals in disease pathogenesis. Pie charts depict the top 25 gene ontology biological pathways (GOBPs) significantly enriched in both patient-derived VEXAS over control monocytes (CD14 + ) and the VEXAS model cells (THP1). While in the transcriptomic comparison ( upper chart ) the majority of the top 25 enriched GOBPs are related to the immune response, the proteomic comparison ( lower chart ) reveals predominantly GOBPs associated with ERAD and Golgi transport. ( F ) Dot plots show gene set enrichment scores for the top 25 dysregulated GOBPs as identified by proteomic comparison of patient-derived control and VEXAS monocytes (CD14 + ). For each CD14 + top dysregulated GOBP, the mean normalized enrichment score (NES) and the Benjamini-Hochberg-adjusted p-values are shown for the two indicated comparisons (CD14 + protein, THP1 protein). n=3 biological replicates for each condition. ( G ) The proteomes of patient derived CD14 + and THP1 model VEXAS cells are highly similarly dysregulated and exhibit altered immune responses and ERAD dysregulation. The volcano plot depicts differentially expressed proteins (DEPs) of healthy donor and VEXAS CD14+ monocytes. DEPs colored in black are significantly regulated in both VEXAS CD14+ and THP1 model cells. Within this overlap, DEPs related to immune responses, ERAD and Golgi transport are highlighted. ( H ) Immunoblot analysis of THP1 model cells with indicated antibodies reveals that loss of cytoplasmic ubiquitylation causes ERAD and Golgi dysregulation.
    Human Thp1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP-1/bio_rxiv__64898__2026__05__26__727520-125-0-3
    Average 99 stars, based on 1 article reviews
    human thp1 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC human monocytic cell line thp1
    A Confocal microscopy images of <t>THP1</t> cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.
    Human Monocytic Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP-1/pmc13201554-281-0-6
    Average 99 stars, based on 1 article reviews
    human monocytic cell line thp1 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen human myeloid leukaemia cell line thp 1 blue
    A Confocal microscopy images of <t>THP1</t> cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.
    Human Myeloid Leukaemia Cell Line Thp 1 Blue, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-Blue+NF-%CE%BAB+Cells/bio_rxiv__64898__2026__05__20__726595-44-1-7
    Average 99 stars, based on 1 article reviews
    human myeloid leukaemia cell line thp 1 blue - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen human thp1 asc gfp monocyte cell line
    A Confocal microscopy images of <t>THP1</t> cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.
    Human Thp1 Asc Gfp Monocyte Cell Line, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-ASC-GFP+Cells/pm42082551-55-38-46
    Average 99 stars, based on 1 article reviews
    human thp1 asc gfp monocyte cell line - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen human tlr9 gene
    PS ASO innate immunogenicity varies with cell system, treatment duration, and concentration. ( A ) Model PS-ASOs used for this study. “o”indicates a phosphodiester linkage; all other linkages are phosphonothioate. Constrained Ethyl (cEt) and MOE 2’ modifications are indicated for each PS-ASO. Fast-acting or slow-acting <t>TLR9</t> agonism is listed as defined by Pollak et al. 2022 (, ). ( B ) Pulse treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 mRNA following a 1, 2, 3, or 4 h incubation with 1.6 µM of the indicated PS ASOs in serum-free RPMI media. RNA lysates were collected 24 h following treatment. ( C ) Continuous treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 following a 2-, 4-, 8-, or 24-h incubation with 1.6 µM of indicated PS ASOs in serum-free RPMI media. RNA lysates were collected immediately following treatment. ( D ) Dose response in BJAB cell line (left) or THP1-TLR9 cell line (right). Cells were treated for 2 h with varying concentrations (0.064, 0.32, 1.6, or 8 µM) of PS ASOs. RNA lysates were collected 24 h after treatment. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.
    Human Tlr9 Gene, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-Dual+hTLR9+Cells/pmc13076217-80-6-3
    Average 99 stars, based on 1 article reviews
    human tlr9 gene - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen human thp1 cell culture immortalized wild type thp1 cells
    PS ASO innate immunogenicity varies with cell system, treatment duration, and concentration. ( A ) Model PS-ASOs used for this study. “o”indicates a phosphodiester linkage; all other linkages are phosphonothioate. Constrained Ethyl (cEt) and MOE 2’ modifications are indicated for each PS-ASO. Fast-acting or slow-acting <t>TLR9</t> agonism is listed as defined by Pollak et al. 2022 (, ). ( B ) Pulse treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 mRNA following a 1, 2, 3, or 4 h incubation with 1.6 µM of the indicated PS ASOs in serum-free RPMI media. RNA lysates were collected 24 h following treatment. ( C ) Continuous treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 following a 2-, 4-, 8-, or 24-h incubation with 1.6 µM of indicated PS ASOs in serum-free RPMI media. RNA lysates were collected immediately following treatment. ( D ) Dose response in BJAB cell line (left) or THP1-TLR9 cell line (right). Cells were treated for 2 h with varying concentrations (0.064, 0.32, 1.6, or 8 µM) of PS ASOs. RNA lysates were collected 24 h after treatment. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.
    Human Thp1 Cell Culture Immortalized Wild Type Thp1 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+thp1+cells/THP1-Null/pm41991983-369-1-12
    Average 99 stars, based on 1 article reviews
    human thp1 cell culture immortalized wild type thp1 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in THP1-Dual-derived macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.

    Journal: PLOS Pathogens

    Article Title: Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production

    doi: 10.1371/journal.ppat.1014364

    Figure Lengend Snippet: (a) Interferon (IFN)-β secretion and (b) Infb1 gene expression in murine macrophage J774a.1 cells stimulated with membrane vesicles (MVs) at the indicated concentrations for 4 h. (c) IFN-β secretion 6 h after stimulation with MVs (multiplicity of infection [MOI]=500) from lps B knockout (Δ lpsB ) strains and their parent wild-type (WT) A. baumannii strains belonging to different sequence types. (d) Cytokine levels in THP1-Dual-derived macrophages 24 h after stimulation with MVs from different strains (MOI = 500). The means and standard error of the means from three biological replicates are shown, with significance being determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (e) Top 5 biological processes identified using gene set enrichment analysis comparing responses to MVs from Ab908 (with intact LOS) and Ab908 ΔlpsB (with Re-LOS) (f) Heatmaps illustrating the expression of genes related to “response to IFN-β”, “cellular response to IFN-β”, and “negative regulation of type I interferon-mediated signaling pathway” in J774a.1 cell in response to the indicated stimuli. The scale numbers of the color keys represent log₂(FC). All data were retrieved from three biological replicates.

    Article Snippet: Human THP1-Dual, THP1-Dual KO‐TRIF, and THP1-Dual KO-MyD88 were purchased from InvivoGen (San Diego, CA, USA).

    Techniques: Gene Expression, Membrane, Infection, Knock-Out, Sequencing, Derivative Assay, Two Tailed Test, Analysis, Expressing, Significance Assay

    (a) Interferon (IFN)-β secretion in J774a.1 macrophages pre-treated with Triton X-100, subjected to freeze–thaw cycles, or sonicated (2 cycles of 25 s each with 5 s pause at 30% power on ice) before being stimulated with Ab908 membrane vesicles (MVs). (b) IFN-β secretion in J774a.1 macrophages pre-treated with DNase I, RNase A, proteinase K, or polymyxin B for 30 min before being stimulated with MVs. (c) IFN-β secretion in THP1-Dual-derived macrophages pre-treated with TAK242 (Toll-like receptor 4 [TLR4] inhibitor) for 1 h and L48H37 (Myeloid differentiation factor-2 [MD-2] inhibitor) for 0.5 h before being stimulated with MVs. (d) IFN-β and (e) TNF-α secretion in THP1-Dual-derived macrophages pre-treated with anti-human CD14 antibody (hCD14) or anti-human IgG (hIgG, control) for 1 h before being stimulated with MVs (multiplicity of infection [MOI] = 500) from different bacterial strains. Cytokines were measured using an enzyme-linked immunosorbent assay 4 h after stimulation. The concentrations used were as follows: Triton X-100 (0.1% vol/vol); DNase I, 1 U/μL; RNase A, 200 μg/mL; proteinase K, 100 μg/mL; polymyxin B, 3 μM; TAK242, 1 μM; L48H37, 10 μM; hIgG, 10 μg/mL; hCD14, 10 μg/mL. Statistical significance was determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01, *** P < 0.001.

    Journal: PLOS Pathogens

    Article Title: Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production

    doi: 10.1371/journal.ppat.1014364

    Figure Lengend Snippet: (a) Interferon (IFN)-β secretion in J774a.1 macrophages pre-treated with Triton X-100, subjected to freeze–thaw cycles, or sonicated (2 cycles of 25 s each with 5 s pause at 30% power on ice) before being stimulated with Ab908 membrane vesicles (MVs). (b) IFN-β secretion in J774a.1 macrophages pre-treated with DNase I, RNase A, proteinase K, or polymyxin B for 30 min before being stimulated with MVs. (c) IFN-β secretion in THP1-Dual-derived macrophages pre-treated with TAK242 (Toll-like receptor 4 [TLR4] inhibitor) for 1 h and L48H37 (Myeloid differentiation factor-2 [MD-2] inhibitor) for 0.5 h before being stimulated with MVs. (d) IFN-β and (e) TNF-α secretion in THP1-Dual-derived macrophages pre-treated with anti-human CD14 antibody (hCD14) or anti-human IgG (hIgG, control) for 1 h before being stimulated with MVs (multiplicity of infection [MOI] = 500) from different bacterial strains. Cytokines were measured using an enzyme-linked immunosorbent assay 4 h after stimulation. The concentrations used were as follows: Triton X-100 (0.1% vol/vol); DNase I, 1 U/μL; RNase A, 200 μg/mL; proteinase K, 100 μg/mL; polymyxin B, 3 μM; TAK242, 1 μM; L48H37, 10 μM; hIgG, 10 μg/mL; hCD14, 10 μg/mL. Statistical significance was determined using an unpaired two-tailed Student’s t-test. * P < 0.05; ** P < 0.01, *** P < 0.001.

    Article Snippet: Human THP1-Dual, THP1-Dual KO‐TRIF, and THP1-Dual KO-MyD88 were purchased from InvivoGen (San Diego, CA, USA).

    Techniques: Sonication, Membrane, Derivative Assay, Control, Infection, Enzyme-linked Immunosorbent Assay, Two Tailed Test

    (a) Tumor necrosis factor (TNF)-α production in THP1-Dual-derived macrophages pre-treated with polymyxin B (3 μM) and subsequently stimulated with membrane vesicles (MVs) from different bacterial strains (multiplicity of infection [MOI] =500). (b) TNF-α levels in THP1-Dual-derived macrophages 6 h after being stimulated with MVs released from the parent strains and their Re-LOS mutants belonging to different sequence types. (c)-(d) Activation of NF-κB and interferon regulator factor (IRF) pathways in THP1-Dual cells based on the activities of secreted embryonic alkaline phosphatase (SEAP) and luciferase, respectively. (e) Expression of interferon regulatory factor 3 (IRF3) and phosphorylated IRF3 (p-IRF3) in J774a.1 cells at 1 h and 6 h post-stimulation with MVs from different strains. (f) IFN-β production at 4 h post-stimulation with MVs (MOI = 500) in the presence or absence of IKKε/TBK1 inhibitor MRT67307 (10 μM, pre-treated for 1 h) . (g) mRNA expression in J774a.1 cell at 2 h post-stimulation with MVs. (h) Expression levels of MyD88-associated genes in cells stimulated with MVs. (i)-(j) TNF-α and IFN-β secretion in macrophages derived from (i) THP1-Dual KO‑TRIF cells and (j ) THP1-Dual KO‑MyD88 cells at 6 h post-stimulation with MVs. Means and standard errors of the means from the three biological replicates are presented, with significance determined using unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. LPS, lipopolysaccharide.

    Journal: PLOS Pathogens

    Article Title: Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production

    doi: 10.1371/journal.ppat.1014364

    Figure Lengend Snippet: (a) Tumor necrosis factor (TNF)-α production in THP1-Dual-derived macrophages pre-treated with polymyxin B (3 μM) and subsequently stimulated with membrane vesicles (MVs) from different bacterial strains (multiplicity of infection [MOI] =500). (b) TNF-α levels in THP1-Dual-derived macrophages 6 h after being stimulated with MVs released from the parent strains and their Re-LOS mutants belonging to different sequence types. (c)-(d) Activation of NF-κB and interferon regulator factor (IRF) pathways in THP1-Dual cells based on the activities of secreted embryonic alkaline phosphatase (SEAP) and luciferase, respectively. (e) Expression of interferon regulatory factor 3 (IRF3) and phosphorylated IRF3 (p-IRF3) in J774a.1 cells at 1 h and 6 h post-stimulation with MVs from different strains. (f) IFN-β production at 4 h post-stimulation with MVs (MOI = 500) in the presence or absence of IKKε/TBK1 inhibitor MRT67307 (10 μM, pre-treated for 1 h) . (g) mRNA expression in J774a.1 cell at 2 h post-stimulation with MVs. (h) Expression levels of MyD88-associated genes in cells stimulated with MVs. (i)-(j) TNF-α and IFN-β secretion in macrophages derived from (i) THP1-Dual KO‑TRIF cells and (j ) THP1-Dual KO‑MyD88 cells at 6 h post-stimulation with MVs. Means and standard errors of the means from the three biological replicates are presented, with significance determined using unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. LPS, lipopolysaccharide.

    Article Snippet: Human THP1-Dual, THP1-Dual KO‐TRIF, and THP1-Dual KO-MyD88 were purchased from InvivoGen (San Diego, CA, USA).

    Techniques: Derivative Assay, Membrane, Infection, Sequencing, Activation Assay, Luciferase, Expressing, Two Tailed Test, Western Blot

    (a) Interferon (IFN)-β measurement in THP1-Dual-derived macrophages (5 × 10 5 /well) pre-treated with dynasore (endocytosis inhibitor, 80 μM) for 1 h, piceatannol (Syk inhibitor, 75 μM), or U-73122 (PLCγ2 inhibitor, 5 μM) for 0.5 h before being stimulated with membrane vesicles (MVs) from different strains (multiplicity of infection [MOI] = 500, 4 h) . n = 3 biological replicates per group. (b)-(d) Flow cytometry results of endocytosis of (b ) CD14, (c ) Toll-like receptor 4 (TLR4), and (d) TLR4/Myeloid differentiation factor-2 (MD-2) dimerization in J774a.1 cells stimulated with MVs for the indicated times. Error bars represent mean ± standard error of the mean (SEM) from triplicate experiments. MFI, mean fluorescence intensity. The means and standard error of mean from three biological replicates are presented, with significance determined by unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001. LPS, lipopolysaccharide.

    Journal: PLOS Pathogens

    Article Title: Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production

    doi: 10.1371/journal.ppat.1014364

    Figure Lengend Snippet: (a) Interferon (IFN)-β measurement in THP1-Dual-derived macrophages (5 × 10 5 /well) pre-treated with dynasore (endocytosis inhibitor, 80 μM) for 1 h, piceatannol (Syk inhibitor, 75 μM), or U-73122 (PLCγ2 inhibitor, 5 μM) for 0.5 h before being stimulated with membrane vesicles (MVs) from different strains (multiplicity of infection [MOI] = 500, 4 h) . n = 3 biological replicates per group. (b)-(d) Flow cytometry results of endocytosis of (b ) CD14, (c ) Toll-like receptor 4 (TLR4), and (d) TLR4/Myeloid differentiation factor-2 (MD-2) dimerization in J774a.1 cells stimulated with MVs for the indicated times. Error bars represent mean ± standard error of the mean (SEM) from triplicate experiments. MFI, mean fluorescence intensity. The means and standard error of mean from three biological replicates are presented, with significance determined by unpaired two-tailed Student’s t-test: * P < 0.05; ** P < 0.01; *** P < 0.001. LPS, lipopolysaccharide.

    Article Snippet: Human THP1-Dual, THP1-Dual KO‐TRIF, and THP1-Dual KO-MyD88 were purchased from InvivoGen (San Diego, CA, USA).

    Techniques: Derivative Assay, Membrane, Infection, Flow Cytometry, Fluorescence, Two Tailed Test

    ( A ) Schematic workflow of proteomic and transcriptomic analyses across both model THP1 monocytes ( left ), and patient derived control and VEXAS monocytes ( right ) to identify disease initiating pathways. ( B ) Loss of cytoplasmic UBA1 function in THP1 model cells leads to ERAD dysregulation, UPR activation, and inflammatory signaling without evidence for cell death. UBA1 WT and UBA1 M41V THP1 cells were treated with dox for 9 d and subjected to immunoblotting using the indicated antibodies. Results are representative of n ≥ 3 biological replicates. ( C ) THP1 VEXAS model cells exhibit type I interferon signatures, confirming the results of the transcriptomic analyses. Parental, UBA1-/-, UBA1 WT and UBA1 M41V/L THP1 monocytes or macrophages (M ϕ) were treated with dox for 9 d and analyzed by qPCR for an Interferon Score by averaging the fold change of 6-hallmark ISGs (IFI44L, IFI27, IFIT1, ISG15, RSAD2, and SIGLEC1). n ≥ 3 biological replicates, error bars = s.e.m., **** = p < 0.0001, student’s t-test. ( D ) Loss of cytoplasmic UBA1 function in THP1 model cells leads to multi-cytokine inflammation. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were treated with dox for 9 d and ELISA for IL-6, TNFα, IL-1b, and CXCL-10. n = 3 biological replicates, ** = p < 0.01, error bar = s.e.m, student’s t-test. ( E ) Proteomic and transcriptomic analyses reveal overlapping and unique altered pathways in VEXAS and nominate ERAD and Golgi transport dysregulation as initial signals in disease pathogenesis. Pie charts depict the top 25 gene ontology biological pathways (GOBPs) significantly enriched in both patient-derived VEXAS over control monocytes (CD14 + ) and the VEXAS model cells (THP1). While in the transcriptomic comparison ( upper chart ) the majority of the top 25 enriched GOBPs are related to the immune response, the proteomic comparison ( lower chart ) reveals predominantly GOBPs associated with ERAD and Golgi transport. ( F ) Dot plots show gene set enrichment scores for the top 25 dysregulated GOBPs as identified by proteomic comparison of patient-derived control and VEXAS monocytes (CD14 + ). For each CD14 + top dysregulated GOBP, the mean normalized enrichment score (NES) and the Benjamini-Hochberg-adjusted p-values are shown for the two indicated comparisons (CD14 + protein, THP1 protein). n=3 biological replicates for each condition. ( G ) The proteomes of patient derived CD14 + and THP1 model VEXAS cells are highly similarly dysregulated and exhibit altered immune responses and ERAD dysregulation. The volcano plot depicts differentially expressed proteins (DEPs) of healthy donor and VEXAS CD14+ monocytes. DEPs colored in black are significantly regulated in both VEXAS CD14+ and THP1 model cells. Within this overlap, DEPs related to immune responses, ERAD and Golgi transport are highlighted. ( H ) Immunoblot analysis of THP1 model cells with indicated antibodies reveals that loss of cytoplasmic ubiquitylation causes ERAD and Golgi dysregulation.

    Journal: bioRxiv

    Article Title: Cell autonomous inflammation in VEXAS is mediated by cGAS-STING

    doi: 10.64898/2026.05.26.727520

    Figure Lengend Snippet: ( A ) Schematic workflow of proteomic and transcriptomic analyses across both model THP1 monocytes ( left ), and patient derived control and VEXAS monocytes ( right ) to identify disease initiating pathways. ( B ) Loss of cytoplasmic UBA1 function in THP1 model cells leads to ERAD dysregulation, UPR activation, and inflammatory signaling without evidence for cell death. UBA1 WT and UBA1 M41V THP1 cells were treated with dox for 9 d and subjected to immunoblotting using the indicated antibodies. Results are representative of n ≥ 3 biological replicates. ( C ) THP1 VEXAS model cells exhibit type I interferon signatures, confirming the results of the transcriptomic analyses. Parental, UBA1-/-, UBA1 WT and UBA1 M41V/L THP1 monocytes or macrophages (M ϕ) were treated with dox for 9 d and analyzed by qPCR for an Interferon Score by averaging the fold change of 6-hallmark ISGs (IFI44L, IFI27, IFIT1, ISG15, RSAD2, and SIGLEC1). n ≥ 3 biological replicates, error bars = s.e.m., **** = p < 0.0001, student’s t-test. ( D ) Loss of cytoplasmic UBA1 function in THP1 model cells leads to multi-cytokine inflammation. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were treated with dox for 9 d and ELISA for IL-6, TNFα, IL-1b, and CXCL-10. n = 3 biological replicates, ** = p < 0.01, error bar = s.e.m, student’s t-test. ( E ) Proteomic and transcriptomic analyses reveal overlapping and unique altered pathways in VEXAS and nominate ERAD and Golgi transport dysregulation as initial signals in disease pathogenesis. Pie charts depict the top 25 gene ontology biological pathways (GOBPs) significantly enriched in both patient-derived VEXAS over control monocytes (CD14 + ) and the VEXAS model cells (THP1). While in the transcriptomic comparison ( upper chart ) the majority of the top 25 enriched GOBPs are related to the immune response, the proteomic comparison ( lower chart ) reveals predominantly GOBPs associated with ERAD and Golgi transport. ( F ) Dot plots show gene set enrichment scores for the top 25 dysregulated GOBPs as identified by proteomic comparison of patient-derived control and VEXAS monocytes (CD14 + ). For each CD14 + top dysregulated GOBP, the mean normalized enrichment score (NES) and the Benjamini-Hochberg-adjusted p-values are shown for the two indicated comparisons (CD14 + protein, THP1 protein). n=3 biological replicates for each condition. ( G ) The proteomes of patient derived CD14 + and THP1 model VEXAS cells are highly similarly dysregulated and exhibit altered immune responses and ERAD dysregulation. The volcano plot depicts differentially expressed proteins (DEPs) of healthy donor and VEXAS CD14+ monocytes. DEPs colored in black are significantly regulated in both VEXAS CD14+ and THP1 model cells. Within this overlap, DEPs related to immune responses, ERAD and Golgi transport are highlighted. ( H ) Immunoblot analysis of THP1 model cells with indicated antibodies reveals that loss of cytoplasmic ubiquitylation causes ERAD and Golgi dysregulation.

    Article Snippet: Human THP1 cells (ATCC, TIB-202) were cultured at 37 °C in a humidified atmosphere with 5% CO2 in RPMI 1640 Medium (Gibco) supplemented with 10% heat-inactivated FBS, 100 U/mL Penicillin-Streptomycin (Gibco), 10 mM HEPES, 1 mM sodium pyruvate, 4500 mg/L glucose, and 1500 mg/L sodium bicarbonate.

    Techniques: Derivative Assay, Control, Activation Assay, Western Blot, Enzyme-linked Immunosorbent Assay, Comparison

    ( A ) ERAD alterations precede inflammation in THP1 VEXAS models, shown via heatmap representation of gene ontology biologic processes (GOBPs) across indicated time periods after doxycycline induction. Representative GOBPs and proteins were selected from those significantly dysregulated in patient CD14 + cell proteomics. Color scale indicates the mean normalized enrichment score (NES) of UBA1 M41V versus UBA1 WT THP1 monocytes with asterisks representing Benjamini-Hochberg-adjusted p-value of -log 10 (p-value) ≥ 1.3. ( B ) ERAD is impaired in VEXAS model cells. UBA1 WT and UBA1 M41V THP1 macrophages expressing the ERAD reporter, CD3d-GFP, were induced with doxycycline for 10 days, treated with cycloheximide (CHX) for indicated time periods, and subjected to immunoblotting with indicated antibodies. CD3d-GFP quantifications were normalized to Actin. N ≥ 3 biologic replicates, error bars = s.e.m., * = p < 0.05, ** = p < 0.01, *** = p < 0.001, students t-test. ( C ) Loss of cytoplasmic UBA1 activity leads to a preferential loss of ubiquitin charging to the ERAD-associated E2 enzymes UBE2J1 and UBE2G2. Schematic depicts the workflow of the biochemical screen to identify E2 charging defects associated with VEXAS mutations. Chinese hamster ovary (CHO) cells with a temperature sensitive Uba1 allele (ts20) and complemented with human UBA1 WT , UBA1 M41V , or UBA1 M41L were incubated at the restrictive temperature and subjected to immunoblotting using antibodies against the 28 detectable E2s in CHO cells. Heatmap depicts the quantifications of the ubiquitin charging status of each E2 enzyme based on immunoblot signal of ubiquitin-charged over total E2, normalized to UBA1 WT . Some E2 enzymes are known to be charged independent of UBA1 (UBA1-independent), while the majority of other E2s show varying degrees of sensitivity to loss of cytoplasmic UBA1 activity (UBE2Ds = UBE2D1/2/3/4). ( D ) Confirmation of the specific E2 charging defect of ERAD-associated UBE2J1 and UBE2G2 in patient cells. CD14 + monocytes from control or VEXAS patients were isolated and subjected to immunoblotting with indicated antibodies. ( E ) Quantification of the ubiquitin charging status for each E2 (E2∼Ub/ total E2) depicted in panel e. n ≥ 4 biological replicates, error bar = s.e.m, ** = p < 0.01, *** = p < 0.001, student’s t-test. ( F ) ERAD inhibition leads to activation of the unfolded protein response (UPR), as shown by immunoblotting for UPR and integrated stress response (ISR) components upon treatment of parental THP1 cells with 5 μM ERAD inhibitor CP26. ( G ) ERAD inhibition leads to cytoplasmic vacuole formation, as assessed via Wright-Giemsa staining after treatment of THP1 cells with the ERAD inhibitors EerI (2.5 μM) and CP26 (5 μM). Vacuoles were quantified via a machine learning algorithm (see methods). n = 3 biologic replicates, **** = p < 0.001, student’s t-test. ( H ) Loss of cytoplasmic UBA1 activity in THP1 cells causes abnormal ER morphology with dilated, vacuole-sized, and proteinaceous cisterna. UBA1 WT and UBA1 M41V THP1 cells were treated with doxycycline for 10 days and analyzed by transmission electron microscopy (TEM, upper panel) or focused ion beam scanning electron microscopy (FIB-SEM, lower panel). For TEM, Representative images of 2 biologic replicates are shown (for quantifications, see Fig. S10). For FIB-SEM, 3D reconstructions depict a representative UBA1 WT and UBA1 M41V THP1 cell, demonstrating dilated ER coursing through the UBA1 M41V THP1 cell. ( I ) VEXAS-associated vacuoles originate from ER, as demonstrated by overlay of brightfield (BF) and confocal anti-calnexin immunofluorescence images of UBA1 WT and UBA1 M41V THP1 cells treated with doxycycline for 10 days in both single plane and maximal intensity projection (max IP). Scale bar = 10 μm

    Journal: bioRxiv

    Article Title: Cell autonomous inflammation in VEXAS is mediated by cGAS-STING

    doi: 10.64898/2026.05.26.727520

    Figure Lengend Snippet: ( A ) ERAD alterations precede inflammation in THP1 VEXAS models, shown via heatmap representation of gene ontology biologic processes (GOBPs) across indicated time periods after doxycycline induction. Representative GOBPs and proteins were selected from those significantly dysregulated in patient CD14 + cell proteomics. Color scale indicates the mean normalized enrichment score (NES) of UBA1 M41V versus UBA1 WT THP1 monocytes with asterisks representing Benjamini-Hochberg-adjusted p-value of -log 10 (p-value) ≥ 1.3. ( B ) ERAD is impaired in VEXAS model cells. UBA1 WT and UBA1 M41V THP1 macrophages expressing the ERAD reporter, CD3d-GFP, were induced with doxycycline for 10 days, treated with cycloheximide (CHX) for indicated time periods, and subjected to immunoblotting with indicated antibodies. CD3d-GFP quantifications were normalized to Actin. N ≥ 3 biologic replicates, error bars = s.e.m., * = p < 0.05, ** = p < 0.01, *** = p < 0.001, students t-test. ( C ) Loss of cytoplasmic UBA1 activity leads to a preferential loss of ubiquitin charging to the ERAD-associated E2 enzymes UBE2J1 and UBE2G2. Schematic depicts the workflow of the biochemical screen to identify E2 charging defects associated with VEXAS mutations. Chinese hamster ovary (CHO) cells with a temperature sensitive Uba1 allele (ts20) and complemented with human UBA1 WT , UBA1 M41V , or UBA1 M41L were incubated at the restrictive temperature and subjected to immunoblotting using antibodies against the 28 detectable E2s in CHO cells. Heatmap depicts the quantifications of the ubiquitin charging status of each E2 enzyme based on immunoblot signal of ubiquitin-charged over total E2, normalized to UBA1 WT . Some E2 enzymes are known to be charged independent of UBA1 (UBA1-independent), while the majority of other E2s show varying degrees of sensitivity to loss of cytoplasmic UBA1 activity (UBE2Ds = UBE2D1/2/3/4). ( D ) Confirmation of the specific E2 charging defect of ERAD-associated UBE2J1 and UBE2G2 in patient cells. CD14 + monocytes from control or VEXAS patients were isolated and subjected to immunoblotting with indicated antibodies. ( E ) Quantification of the ubiquitin charging status for each E2 (E2∼Ub/ total E2) depicted in panel e. n ≥ 4 biological replicates, error bar = s.e.m, ** = p < 0.01, *** = p < 0.001, student’s t-test. ( F ) ERAD inhibition leads to activation of the unfolded protein response (UPR), as shown by immunoblotting for UPR and integrated stress response (ISR) components upon treatment of parental THP1 cells with 5 μM ERAD inhibitor CP26. ( G ) ERAD inhibition leads to cytoplasmic vacuole formation, as assessed via Wright-Giemsa staining after treatment of THP1 cells with the ERAD inhibitors EerI (2.5 μM) and CP26 (5 μM). Vacuoles were quantified via a machine learning algorithm (see methods). n = 3 biologic replicates, **** = p < 0.001, student’s t-test. ( H ) Loss of cytoplasmic UBA1 activity in THP1 cells causes abnormal ER morphology with dilated, vacuole-sized, and proteinaceous cisterna. UBA1 WT and UBA1 M41V THP1 cells were treated with doxycycline for 10 days and analyzed by transmission electron microscopy (TEM, upper panel) or focused ion beam scanning electron microscopy (FIB-SEM, lower panel). For TEM, Representative images of 2 biologic replicates are shown (for quantifications, see Fig. S10). For FIB-SEM, 3D reconstructions depict a representative UBA1 WT and UBA1 M41V THP1 cell, demonstrating dilated ER coursing through the UBA1 M41V THP1 cell. ( I ) VEXAS-associated vacuoles originate from ER, as demonstrated by overlay of brightfield (BF) and confocal anti-calnexin immunofluorescence images of UBA1 WT and UBA1 M41V THP1 cells treated with doxycycline for 10 days in both single plane and maximal intensity projection (max IP). Scale bar = 10 μm

    Article Snippet: Human THP1 cells (ATCC, TIB-202) were cultured at 37 °C in a humidified atmosphere with 5% CO2 in RPMI 1640 Medium (Gibco) supplemented with 10% heat-inactivated FBS, 100 U/mL Penicillin-Streptomycin (Gibco), 10 mM HEPES, 1 mM sodium pyruvate, 4500 mg/L glucose, and 1500 mg/L sodium bicarbonate.

    Techniques: Expressing, Western Blot, Activity Assay, Ubiquitin Proteomics, Incubation, Control, Isolation, Inhibition, Activation Assay, Staining, Transmission Assay, Electron Microscopy, Immunofluorescence

    ( A ) STING is the sole immune response-related ERAD/ HRD1 substrate that accumulates in VEXAS CD14 + cells. The volcano plot depicts differentially expressed proteins (DEPs) of healthy donor and VEXAS CD14 + monocytes. DEPs colored in black highlight previously identified HRD1 substrates and DEPs in blue highlight HRD1 substrates significantly upregulated in VEXAS CD14 + cells. ( B ) Innate immune adaptor STING accumulates in VEXAS-patient derived CD14 + cells, UBA1 M41V THP1 monocytes, UBA1 M41L 32D cells, and upon ERAD inhibition (CP26, 1 μM or 2 μM for 24h), but not upon autophagy inhibition (BafA, 1 μM or 10 μM for 24h) or ESCRT-mediated degradation pathway inhibition (NSC69, 3 μM and 4 μM for 24h) in THP1 parental cells, as quantified from anti-STING immunoblots. n ≥ 3 biologic replicates as indicated, error bar = s.e.m, * = p < 0.05, ** = p < 0.01, student’s t-test. ( C ) The STING pathway is active in CD14 + cells from VEXAS patients, as shown via immunoblotting of cell lysates with indicated antibodies. (D ) The STING pathway is active in UBA1 M41V THP1 monocytes as shown via immunoblotting of cell lysates with indicated antibodies. (E) STING is activated in VEXAS model cells, as evidenced by increased STING trafficking to the Golgi in UBA1 M41V THP1 monocytes observed by anti-STING and anti-GM130 immunofluorescence. Scale bar = 10 μm. ( F ) Quantification of the percentage of Golgi-localized STING of the experiment shown in panel e. n ≥ 150 cells across 10 fields, error bar = s.e.m, **** = p < 0.0001, student’s t-test. ( G ) STING inhibition reverses VEXAS-associated inflammatory signaling in THP1 model cells. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were treated with STING inhibitors H-151 (1 μM) and SN-011 (10 μM) for 24h and subjected to immunoblot analysis using indicated antibodies. ( H ) Schematic representation of experimental design for STING or cGAS knockout (KO) and assessment of inflammation. ( I ) STING or cGAS KO inhibit VEXAS-associated inflammatory signaling in THP1 model cells. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were electroporated with indicated gRNAs and subjected to immunoblot analysis using indicated antibodies. ( J ) Graphs depict quantifications of p-STAT1/STAT1 ratio normalized to control gRNA-electroporated UBA1 WT THP1 macrophages. n = 3 biological replicates, error bar = s.e.m, ** = p < 0.01, student’s t-test. ( K ) STING and cGAS KO inhibit VEXAS-associated inflammatory signaling in THP1 model cells. Same experiments as in panel I, but cell lysates were either subjected to qPCR analysis to determine mRNA levels of different type I interferon stimulated genes ( left graph , IFN score), or cell supernatants were subjected to ELISA to measure secreted protein concentrations of TNFα ( middle graph ) or IL-6 ( right graph ). ( L ) Scheme depicting molecular events triggered by canonical VEXAS mutations in myeloid cells. Loss of cytoplasmic UBA1 activity causes ERAD impairment, which induces UPR/ISR signaling, vacuoles, and accumulation of the innate immune adaptor STING, which is activated in a cGAS-dependent manner.

    Journal: bioRxiv

    Article Title: Cell autonomous inflammation in VEXAS is mediated by cGAS-STING

    doi: 10.64898/2026.05.26.727520

    Figure Lengend Snippet: ( A ) STING is the sole immune response-related ERAD/ HRD1 substrate that accumulates in VEXAS CD14 + cells. The volcano plot depicts differentially expressed proteins (DEPs) of healthy donor and VEXAS CD14 + monocytes. DEPs colored in black highlight previously identified HRD1 substrates and DEPs in blue highlight HRD1 substrates significantly upregulated in VEXAS CD14 + cells. ( B ) Innate immune adaptor STING accumulates in VEXAS-patient derived CD14 + cells, UBA1 M41V THP1 monocytes, UBA1 M41L 32D cells, and upon ERAD inhibition (CP26, 1 μM or 2 μM for 24h), but not upon autophagy inhibition (BafA, 1 μM or 10 μM for 24h) or ESCRT-mediated degradation pathway inhibition (NSC69, 3 μM and 4 μM for 24h) in THP1 parental cells, as quantified from anti-STING immunoblots. n ≥ 3 biologic replicates as indicated, error bar = s.e.m, * = p < 0.05, ** = p < 0.01, student’s t-test. ( C ) The STING pathway is active in CD14 + cells from VEXAS patients, as shown via immunoblotting of cell lysates with indicated antibodies. (D ) The STING pathway is active in UBA1 M41V THP1 monocytes as shown via immunoblotting of cell lysates with indicated antibodies. (E) STING is activated in VEXAS model cells, as evidenced by increased STING trafficking to the Golgi in UBA1 M41V THP1 monocytes observed by anti-STING and anti-GM130 immunofluorescence. Scale bar = 10 μm. ( F ) Quantification of the percentage of Golgi-localized STING of the experiment shown in panel e. n ≥ 150 cells across 10 fields, error bar = s.e.m, **** = p < 0.0001, student’s t-test. ( G ) STING inhibition reverses VEXAS-associated inflammatory signaling in THP1 model cells. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were treated with STING inhibitors H-151 (1 μM) and SN-011 (10 μM) for 24h and subjected to immunoblot analysis using indicated antibodies. ( H ) Schematic representation of experimental design for STING or cGAS knockout (KO) and assessment of inflammation. ( I ) STING or cGAS KO inhibit VEXAS-associated inflammatory signaling in THP1 model cells. UBA1 WT and UBA1 M41V THP1 macrophages (Mϕ) were electroporated with indicated gRNAs and subjected to immunoblot analysis using indicated antibodies. ( J ) Graphs depict quantifications of p-STAT1/STAT1 ratio normalized to control gRNA-electroporated UBA1 WT THP1 macrophages. n = 3 biological replicates, error bar = s.e.m, ** = p < 0.01, student’s t-test. ( K ) STING and cGAS KO inhibit VEXAS-associated inflammatory signaling in THP1 model cells. Same experiments as in panel I, but cell lysates were either subjected to qPCR analysis to determine mRNA levels of different type I interferon stimulated genes ( left graph , IFN score), or cell supernatants were subjected to ELISA to measure secreted protein concentrations of TNFα ( middle graph ) or IL-6 ( right graph ). ( L ) Scheme depicting molecular events triggered by canonical VEXAS mutations in myeloid cells. Loss of cytoplasmic UBA1 activity causes ERAD impairment, which induces UPR/ISR signaling, vacuoles, and accumulation of the innate immune adaptor STING, which is activated in a cGAS-dependent manner.

    Article Snippet: Human THP1 cells (ATCC, TIB-202) were cultured at 37 °C in a humidified atmosphere with 5% CO2 in RPMI 1640 Medium (Gibco) supplemented with 10% heat-inactivated FBS, 100 U/mL Penicillin-Streptomycin (Gibco), 10 mM HEPES, 1 mM sodium pyruvate, 4500 mg/L glucose, and 1500 mg/L sodium bicarbonate.

    Techniques: Derivative Assay, Inhibition, Western Blot, Immunofluorescence, Knock-Out, Control, Enzyme-linked Immunosorbent Assay, Activity Assay

    ( A ) Vacuole-containing VEXAS THP1 cells contain less mitochondria, as demonstrated by brightfield (BF) and single-plane confocal anti-TOM20 immunofluorescence images of UBA1 WT and UBA1 M41V THP1 monocytes treated with doxycycline for 10 d. Representative images of 2 biological replicates are shown. For more examples, see Fig. S16. Scale bar = 10 μm. ( B ) UBA1 M41V THP1 monocytes exhibit mitochondrial morphology abnormalities, indicative of impaired function. UBA1 WT and UBA1 M41V THP1 cells were treated with dox for 10 d and analyzed by transmission electron microscopy. Scale bar = 1 μm. Red arrowheads point to dilated cristae often seen in UBA1 M41V mitochondria (see also Movie S2) ( C ) UBA1 M41V THP1 monocytes exhibit a higher percentage of mitochondria with dilated cristae per cell as compared to UBA1 WT control cells. Graphs depict quantifications of mitochondrial morphology on TEM images of the experiment shown in panel b. n > 20 cells, error bar = s.e.m, * = p < 0.05, ** = p < 0.01, student’s t-test. ( D ) VEXAS THP1 cells exhibit elevated levels of cytoplasmic mitochondrial DNA, as revealed by qPCR analysis of whole cell or cytoplasmic fractions of UBA1 WT and UBA1 M41V THP1 monocytes. n = 3 biological replicates with 2 technical replicates for two different mitochondrial DNA probes (see methods), error bar = s.e.m, ** = p < 0.01, student’s t-test. ( E ) Schematic representation of experimental design to test whether mtDNA release into the cytosol activates cGAS-STING-based VEXAS inflammation. ( F ) Blocking mtDNA release into the cytosol using either a scavenger of reactive oxygen species (MitoTEMPO), an inhibitor of VDAC oligomerization (VBIT4), or an inhibitor of the mitochondrial permeability transition pore (CsA) dampens STING signaling and attenuates VEXAS inflammation in THP1 UBA1 M41V model cells. UBA1 WT and UBA1 M41V THP1 monocytes were treated with indicated inhibitors (10 μM MitoTEMPO, 10 μM VDAC, and 1 μM CsA) for 24h and subjected to immunoblot analysis using indicated antibodies. Graphs depict quantifications of p-STING/STING, p-STAT1/STAT1, or p-STAT3/STAT3 ratio normalized to DMSO-treated UBA1 WT THP1 monocytes. n = 3 biological replicates, error bar = s.e.m, * = p < 0.05, ** = p < 0.01, student’s t-test. ( G ) Blocking mtDNA release into the cytosol restores STING localization by preventing its trafficking to the Golgi, as evidenced by anti-STING and anti-GM130 immunofluorescence analysis of THP1 model monocytes treated as described in panel F. ( H ) Quantification of the percentage of Golgi-localized STING of the experiment depicted in panel g. n ≥ 150 cells across 10 fields, error bar = s.e.m, **** = p < 0.0001, one-way ANOVA. ( I ) Verification that treatment of THP1 VEXAS model cells with indicated inhibitors blocks mtDNA release into the cytosol, as revealed by qPCR analysis of cytoplasmic fractions of UBA1 WT and UBA1 M41V THP1 monocytes. n = 3 biological replicates, 2 technical replicates for two different mitochondrial DNA probes (see methods), error bar = s.e.m, **** = p < 0.0001, one-way ANOVA. (J) Scheme depicting the molecular mechanisms triggering STING activation in VEXAS myeloid cells. Mitochondria in VEXAS myeloid cells are defective and release mtDNA into the cytosol, causing activation of cGAS-STING signaling, which drives multi-cytokine inflammation.

    Journal: bioRxiv

    Article Title: Cell autonomous inflammation in VEXAS is mediated by cGAS-STING

    doi: 10.64898/2026.05.26.727520

    Figure Lengend Snippet: ( A ) Vacuole-containing VEXAS THP1 cells contain less mitochondria, as demonstrated by brightfield (BF) and single-plane confocal anti-TOM20 immunofluorescence images of UBA1 WT and UBA1 M41V THP1 monocytes treated with doxycycline for 10 d. Representative images of 2 biological replicates are shown. For more examples, see Fig. S16. Scale bar = 10 μm. ( B ) UBA1 M41V THP1 monocytes exhibit mitochondrial morphology abnormalities, indicative of impaired function. UBA1 WT and UBA1 M41V THP1 cells were treated with dox for 10 d and analyzed by transmission electron microscopy. Scale bar = 1 μm. Red arrowheads point to dilated cristae often seen in UBA1 M41V mitochondria (see also Movie S2) ( C ) UBA1 M41V THP1 monocytes exhibit a higher percentage of mitochondria with dilated cristae per cell as compared to UBA1 WT control cells. Graphs depict quantifications of mitochondrial morphology on TEM images of the experiment shown in panel b. n > 20 cells, error bar = s.e.m, * = p < 0.05, ** = p < 0.01, student’s t-test. ( D ) VEXAS THP1 cells exhibit elevated levels of cytoplasmic mitochondrial DNA, as revealed by qPCR analysis of whole cell or cytoplasmic fractions of UBA1 WT and UBA1 M41V THP1 monocytes. n = 3 biological replicates with 2 technical replicates for two different mitochondrial DNA probes (see methods), error bar = s.e.m, ** = p < 0.01, student’s t-test. ( E ) Schematic representation of experimental design to test whether mtDNA release into the cytosol activates cGAS-STING-based VEXAS inflammation. ( F ) Blocking mtDNA release into the cytosol using either a scavenger of reactive oxygen species (MitoTEMPO), an inhibitor of VDAC oligomerization (VBIT4), or an inhibitor of the mitochondrial permeability transition pore (CsA) dampens STING signaling and attenuates VEXAS inflammation in THP1 UBA1 M41V model cells. UBA1 WT and UBA1 M41V THP1 monocytes were treated with indicated inhibitors (10 μM MitoTEMPO, 10 μM VDAC, and 1 μM CsA) for 24h and subjected to immunoblot analysis using indicated antibodies. Graphs depict quantifications of p-STING/STING, p-STAT1/STAT1, or p-STAT3/STAT3 ratio normalized to DMSO-treated UBA1 WT THP1 monocytes. n = 3 biological replicates, error bar = s.e.m, * = p < 0.05, ** = p < 0.01, student’s t-test. ( G ) Blocking mtDNA release into the cytosol restores STING localization by preventing its trafficking to the Golgi, as evidenced by anti-STING and anti-GM130 immunofluorescence analysis of THP1 model monocytes treated as described in panel F. ( H ) Quantification of the percentage of Golgi-localized STING of the experiment depicted in panel g. n ≥ 150 cells across 10 fields, error bar = s.e.m, **** = p < 0.0001, one-way ANOVA. ( I ) Verification that treatment of THP1 VEXAS model cells with indicated inhibitors blocks mtDNA release into the cytosol, as revealed by qPCR analysis of cytoplasmic fractions of UBA1 WT and UBA1 M41V THP1 monocytes. n = 3 biological replicates, 2 technical replicates for two different mitochondrial DNA probes (see methods), error bar = s.e.m, **** = p < 0.0001, one-way ANOVA. (J) Scheme depicting the molecular mechanisms triggering STING activation in VEXAS myeloid cells. Mitochondria in VEXAS myeloid cells are defective and release mtDNA into the cytosol, causing activation of cGAS-STING signaling, which drives multi-cytokine inflammation.

    Article Snippet: Human THP1 cells (ATCC, TIB-202) were cultured at 37 °C in a humidified atmosphere with 5% CO2 in RPMI 1640 Medium (Gibco) supplemented with 10% heat-inactivated FBS, 100 U/mL Penicillin-Streptomycin (Gibco), 10 mM HEPES, 1 mM sodium pyruvate, 4500 mg/L glucose, and 1500 mg/L sodium bicarbonate.

    Techniques: Immunofluorescence, Transmission Assay, Electron Microscopy, Control, Blocking Assay, Permeability, Western Blot, Activation Assay

    A Confocal microscopy images of THP1 cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.

    Journal: Cell Death & Disease

    Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

    doi: 10.1038/s41419-026-08916-6

    Figure Lengend Snippet: A Confocal microscopy images of THP1 cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.

    Article Snippet: Human monocytic cell line THP1 (TIB-202, ATCC, Manassas, VA, USA) were propagated in RPMI medium (Gibco, Waltham, Massachusetts, USA) containing 50 μM β-mercaptoethanol (Gibco), Glutamax 2 mM (Gibco), sodium pyruvate 1 mM (Gibco), HEPES 10 mM (Gibco), gentamicin 50 μg/mL (Sanofi-Aventis) and 10% fetal bovine serum (Sigma-Aldrich) at 37 °C in a humidified 5% CO 2 atmosphere.

    Techniques: Confocal Microscopy, Staining, Fluorescence, Flow Cytometry

    PS ASO innate immunogenicity varies with cell system, treatment duration, and concentration. ( A ) Model PS-ASOs used for this study. “o”indicates a phosphodiester linkage; all other linkages are phosphonothioate. Constrained Ethyl (cEt) and MOE 2’ modifications are indicated for each PS-ASO. Fast-acting or slow-acting TLR9 agonism is listed as defined by Pollak et al. 2022 (, ). ( B ) Pulse treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 mRNA following a 1, 2, 3, or 4 h incubation with 1.6 µM of the indicated PS ASOs in serum-free RPMI media. RNA lysates were collected 24 h following treatment. ( C ) Continuous treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 following a 2-, 4-, 8-, or 24-h incubation with 1.6 µM of indicated PS ASOs in serum-free RPMI media. RNA lysates were collected immediately following treatment. ( D ) Dose response in BJAB cell line (left) or THP1-TLR9 cell line (right). Cells were treated for 2 h with varying concentrations (0.064, 0.32, 1.6, or 8 µM) of PS ASOs. RNA lysates were collected 24 h after treatment. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Journal: Nucleic Acids Research

    Article Title: Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products

    doi: 10.1093/nar/gkag311

    Figure Lengend Snippet: PS ASO innate immunogenicity varies with cell system, treatment duration, and concentration. ( A ) Model PS-ASOs used for this study. “o”indicates a phosphodiester linkage; all other linkages are phosphonothioate. Constrained Ethyl (cEt) and MOE 2’ modifications are indicated for each PS-ASO. Fast-acting or slow-acting TLR9 agonism is listed as defined by Pollak et al. 2022 (, ). ( B ) Pulse treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 mRNA following a 1, 2, 3, or 4 h incubation with 1.6 µM of the indicated PS ASOs in serum-free RPMI media. RNA lysates were collected 24 h following treatment. ( C ) Continuous treatment in the BJAB cell line (left) and the THP1-TLR9 cell line (right). Relative qRT-PCR levels of CCL22 following a 2-, 4-, 8-, or 24-h incubation with 1.6 µM of indicated PS ASOs in serum-free RPMI media. RNA lysates were collected immediately following treatment. ( D ) Dose response in BJAB cell line (left) or THP1-TLR9 cell line (right). Cells were treated for 2 h with varying concentrations (0.064, 0.32, 1.6, or 8 µM) of PS ASOs. RNA lysates were collected 24 h after treatment. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Article Snippet: THP1-Dual hTLR9 cells (InvivoGen) overexpress the human TLR9 gene and are engineered with two secreted reporters.

    Techniques: Immunopeptidomics, Concentration Assay, Quantitative RT-PCR, Incubation

    Differential kinetics of cytokine secretion following PS ASO stimulation in BJAB and THP1-TLR9 cells. THP1-TLR9 (left) and BJAB cells (right) were treated with 1.6 μM of the indicated PS ASOs for 2 h, before supernatants were collected for cytokine analysis of TNF-α ( A ) and IL-10 ( B ). THP1-TLR9 cells were also assessed for levels of secreted IL-1β ( C ) and IL-6 ( D ). Values were interpolated to a standard curve of known protein concentration, and are expressed as mean at each time point. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Journal: Nucleic Acids Research

    Article Title: Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products

    doi: 10.1093/nar/gkag311

    Figure Lengend Snippet: Differential kinetics of cytokine secretion following PS ASO stimulation in BJAB and THP1-TLR9 cells. THP1-TLR9 (left) and BJAB cells (right) were treated with 1.6 μM of the indicated PS ASOs for 2 h, before supernatants were collected for cytokine analysis of TNF-α ( A ) and IL-10 ( B ). THP1-TLR9 cells were also assessed for levels of secreted IL-1β ( C ) and IL-6 ( D ). Values were interpolated to a standard curve of known protein concentration, and are expressed as mean at each time point. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Article Snippet: THP1-Dual hTLR9 cells (InvivoGen) overexpress the human TLR9 gene and are engineered with two secreted reporters.

    Techniques: Protein Concentration

    Trp degradation enzymes, IDO1 and IL4I1 , are upregulated in immune cells stimulated with PS ASOs. ( A ) Correlation of tryptophan oxidation enzymes and TLR9 activation in BJAB cells (top) and THP1-TLR9 cells (bottom) after treatment with 1.6 µM of the indicated PS ASOs for 2 h. Relative qRT-PCR levels of CCL22 and IL4I1/IDO1 mRNA were measured at 8, 24, 48, and 72 h post-treatment. Spearman’s rank correlation was used to assess the association between CCL22 mRNA and IL4I1/IDO1 mRNA. ( B ) Maximum values observed in each experiment with the indicated PS ASOs for BJAB cells (top) and THP1-TLR9 cells (bottom). ( C ) Kinetics of IL4I1 and CCL22 qRT-PCR levels in BJAB cells, and ( D ) THP1-TLR9 cells after dosing with the indicated PS ASOs. All data are presented as a percentage of UTC control (mRNA expression/Ribogreen/UTC) and expressed as mean ± S.E.M. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Journal: Nucleic Acids Research

    Article Title: Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products

    doi: 10.1093/nar/gkag311

    Figure Lengend Snippet: Trp degradation enzymes, IDO1 and IL4I1 , are upregulated in immune cells stimulated with PS ASOs. ( A ) Correlation of tryptophan oxidation enzymes and TLR9 activation in BJAB cells (top) and THP1-TLR9 cells (bottom) after treatment with 1.6 µM of the indicated PS ASOs for 2 h. Relative qRT-PCR levels of CCL22 and IL4I1/IDO1 mRNA were measured at 8, 24, 48, and 72 h post-treatment. Spearman’s rank correlation was used to assess the association between CCL22 mRNA and IL4I1/IDO1 mRNA. ( B ) Maximum values observed in each experiment with the indicated PS ASOs for BJAB cells (top) and THP1-TLR9 cells (bottom). ( C ) Kinetics of IL4I1 and CCL22 qRT-PCR levels in BJAB cells, and ( D ) THP1-TLR9 cells after dosing with the indicated PS ASOs. All data are presented as a percentage of UTC control (mRNA expression/Ribogreen/UTC) and expressed as mean ± S.E.M. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Article Snippet: THP1-Dual hTLR9 cells (InvivoGen) overexpress the human TLR9 gene and are engineered with two secreted reporters.

    Techniques: Activation Assay, Quantitative RT-PCR, Control, Expressing

    Immunogenic PS ASOs stimulate Kyn production via the tryptophan catabolism pathway, and genetic manipulation of tryptophan catabolizing enzymes alters TLR9-mediated PS ASO activation. Total extracellular ( A ) tryptophan and ( B ) kynurenine metabolite levels from THP1-TLR9 cells 24- or 48-h post-treatment with 0.32, 1.6, or 8 μM of indicated PS ASOs. ( C ) Relative CCL22 and IDO1 mRNA expression levels in IDO1 siRNA-treated THP1-TLR9 stimulated with CpG ASO. ( D ) Validation of IDO1 siRNA knockdown and representative western blot measuring IDO1 protein expression. THP1-TLR9 cells were electroporated with 1 μM of siRNA 24 h prior to treatment with 1.6 μM CpG ASO for 2 h. Protein lysates were collected 24 h following treatment. ( E ) Relative CCL22 and IL4I1 mRNA expression levels in IL4I1 overexpression plasmid-treated BJAB cells stimulated with CpG ASO. All bar graph data are expressed as mean ± S.E.M.

    Journal: Nucleic Acids Research

    Article Title: Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products

    doi: 10.1093/nar/gkag311

    Figure Lengend Snippet: Immunogenic PS ASOs stimulate Kyn production via the tryptophan catabolism pathway, and genetic manipulation of tryptophan catabolizing enzymes alters TLR9-mediated PS ASO activation. Total extracellular ( A ) tryptophan and ( B ) kynurenine metabolite levels from THP1-TLR9 cells 24- or 48-h post-treatment with 0.32, 1.6, or 8 μM of indicated PS ASOs. ( C ) Relative CCL22 and IDO1 mRNA expression levels in IDO1 siRNA-treated THP1-TLR9 stimulated with CpG ASO. ( D ) Validation of IDO1 siRNA knockdown and representative western blot measuring IDO1 protein expression. THP1-TLR9 cells were electroporated with 1 μM of siRNA 24 h prior to treatment with 1.6 μM CpG ASO for 2 h. Protein lysates were collected 24 h following treatment. ( E ) Relative CCL22 and IL4I1 mRNA expression levels in IL4I1 overexpression plasmid-treated BJAB cells stimulated with CpG ASO. All bar graph data are expressed as mean ± S.E.M.

    Article Snippet: THP1-Dual hTLR9 cells (InvivoGen) overexpress the human TLR9 gene and are engineered with two secreted reporters.

    Techniques: Activation Assay, Expressing, Biomarker Discovery, Knockdown, Western Blot, Over Expression, Plasmid Preparation

    Directed metabolomics of tryptophan metabolites after PS ASO treatment in THP1-TLR9 cells. Cells were treated with 8 μM PS-ASOs for 2 h, recovered for 48 h, and the collected cellular supernatant was subjected to directed metabolomic analysis of tryptophan metabolites to quantify specific changes. Biological replicates ( n = 3) were submitted for metabolomic analysis. Significant differences in means of metabolite quantities (ng/mL) were determined via one-way ANOVA with Dunnett post-hoc tests (statistical significance is denoted at P < 0.05*, P < 0.005**, and P < 0.0005***).

    Journal: Nucleic Acids Research

    Article Title: Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products

    doi: 10.1093/nar/gkag311

    Figure Lengend Snippet: Directed metabolomics of tryptophan metabolites after PS ASO treatment in THP1-TLR9 cells. Cells were treated with 8 μM PS-ASOs for 2 h, recovered for 48 h, and the collected cellular supernatant was subjected to directed metabolomic analysis of tryptophan metabolites to quantify specific changes. Biological replicates ( n = 3) were submitted for metabolomic analysis. Significant differences in means of metabolite quantities (ng/mL) were determined via one-way ANOVA with Dunnett post-hoc tests (statistical significance is denoted at P < 0.05*, P < 0.005**, and P < 0.0005***).

    Article Snippet: THP1-Dual hTLR9 cells (InvivoGen) overexpress the human TLR9 gene and are engineered with two secreted reporters.

    Techniques: Metabolomic

    Exogenous kynurenine and indole metabolites attenuate PS-ASO-induced innate immune responses. ( A ) Relative CCL22 mRNA expression levels in BJAB and THP1-TLR9 cells and ( B ) Relative IRF reporter activity and NF-kB reporter activity in THP1-TLR9 cells following treatment with 100 µM of the indicated metabolite and 0.8 µM CpG ASO. Relative TLR9 activation of ( C ) THP1-TLR9 cells and ( D ) BJAB cells pretreated with various doses (1.5 mM–0.08 µM) of kynurenine, kynurenic acid, 3-hydroxy anthranilic acid, and indole-3-pyruvate for 2 h, and subsequently treated with 1.6 µM of ASO-20 or ASO-95 for 24 h. TLR9 activation was measured as CCL22 mRNA expression. Metabolite IC50s derived from the top five doses are shown for each ASO, calculated using linear regression with normalized response and variable slope. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Journal: Nucleic Acids Research

    Article Title: Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products

    doi: 10.1093/nar/gkag311

    Figure Lengend Snippet: Exogenous kynurenine and indole metabolites attenuate PS-ASO-induced innate immune responses. ( A ) Relative CCL22 mRNA expression levels in BJAB and THP1-TLR9 cells and ( B ) Relative IRF reporter activity and NF-kB reporter activity in THP1-TLR9 cells following treatment with 100 µM of the indicated metabolite and 0.8 µM CpG ASO. Relative TLR9 activation of ( C ) THP1-TLR9 cells and ( D ) BJAB cells pretreated with various doses (1.5 mM–0.08 µM) of kynurenine, kynurenic acid, 3-hydroxy anthranilic acid, and indole-3-pyruvate for 2 h, and subsequently treated with 1.6 µM of ASO-20 or ASO-95 for 24 h. TLR9 activation was measured as CCL22 mRNA expression. Metabolite IC50s derived from the top five doses are shown for each ASO, calculated using linear regression with normalized response and variable slope. All experiments were reproduced in at least three independent biological experiments, with multiple replicates per experiment.

    Article Snippet: THP1-Dual hTLR9 cells (InvivoGen) overexpress the human TLR9 gene and are engineered with two secreted reporters.

    Techniques: Expressing, Activity Assay, Activation Assay, Derivative Assay